Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Income Quality Over TimeContracting
Percentile Rank14
3Y CAGR-65.4%
5Y CAGR-36.4%
Studio
Year-over-Year Change

Quality of reported income

3Y CAGR
-65.4%/yr
vs +27.0%/yr prior
5Y CAGR
-36.4%/yr
Recent deceleration
Acceleration
-92.5pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive growthContracting
PeriodValueYoY Change
20250.10+150.3%
2024-0.20+32.8%
2023-0.30-112.2%
20222.47+159.8%
20210.95-2.7%
20200.98+23.8%
20190.79-16.8%
20180.95+2.7%
20170.92-15.2%
20161.09-